Loading insider details...
Beta
Latest Form 4 (Jul 9, 2026): Grant/Award of 6,800 CRIS shares, $36.0K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 9, 2026 | CURIS INC (CRIS) | Grant/Award | 6,800 | $36.0K |
| Mar 23, 2026 | CURIS INC (CRIS) | Conversion | 26,667 | n/a |
| Mar 18, 2026 | CURIS INC (CRIS) | Grant/Award | 20 | n/a |
| May 22, 2025 | CURIS INC (CRIS) | Grant/Award | 14,400 | $45.1K |
| Jan 30, 2025 | CURIS INC (CRIS) | Grant/Award | 1,600 | $5.0K |
| Jan 27, 2025 | GALECTIN THERAPEUTICS INC (GALT) | Grant/Award | 60,000 | n/a |
| May 23, 2024 | CURIS INC (CRIS) | Grant/Award | 4,250 | $49.4K |
| Feb 7, 2024 | GALECTIN THERAPEUTICS INC (GALT) | Grant/Award | 50,000 | n/a |
| Jan 30, 2023 | GALECTIN THERAPEUTICS INC (GALT) | Grant/Award | 40,000 | n/a |
| Jan 24, 2023 | CURIS INC (CRIS) | Grant/Award | 85,000 | n/a |